Bilateral Nucleus Accumbens Focused Ultrasound Neuromodulation for Stimulant Use Disorder
NCT: NCT06474026 · RECRUITING
Publicidade
Resumo breve
The purpose of this clinical trial is to evaluate the initial safety and efficacy of the ExAblate Model 4000 Type 2.1 surgical device for nucleus accumbens (NAc) neuromodulation in patients with psychostimulant use disorder (PUD).
Fonte oficial
Ver no ClinicalTrials.gov →Dados provenientes da API do ClinicalTrials.gov. Para consultar o estado mais recente, veja o registo oficial.